25 XP   0   0   10

Better Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Better Therapeutics Inc together

PenkeI guess you are interested in Better Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Better Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Better Therapeutics Inc

I send you an email if I find something interesting about Better Therapeutics Inc.

Quick analysis of Better Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Better Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$-2.78
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-2.76
Return On Investment
-44,520.0%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.005 - $0.0135
How sure are you?
50%

1. Valuation of Better Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-7.94 - $-9.46

Total Value Per Share

$-7.95 - $-9.47

2. Growth of Better Therapeutics Inc (5 min.)




Is Better Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$899k$36.7m-$37.6m-4,184.5%

How much money is Better Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$39.7m-$40.3m$575k1.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Better Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#876 / 1010

Most Revenue
#887 / 1010

Most Profit
#857 / 1010

Most Efficient
#327 / 1010

What can you expect buying and holding a share of Better Therapeutics Inc? (5 min.)

Welcome investor! Better Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Better Therapeutics Inc.

What can you expect buying and holding a share of Better Therapeutics Inc?

First you should know what it really means to hold a share of Better Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Better Therapeutics Inc is $0.0062. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Better Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Better Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $-0.69 per quarter. Based on the YOY, the Book Value Change Per Share is $0.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Better Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.73-11,763.4%-0.73-11,763.4%-0.74-11,933.5%-0.45-7,295.0%-0.45-7,295.0%
Usd Book Value Change Per Share-0.69-11,130.0%-0.69-11,130.0%0.8012,863.4%0.00-66.5%0.00-66.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.69-11,130.0%-0.69-11,130.0%0.8012,863.4%0.00-66.5%0.00-66.5%
Usd Price Per Share1.11-1.11-4.65-1.44-1.44-
Price to Earnings Ratio-1.52--1.52--6.28--1.95--1.95-
Price-to-Total Gains Ratio-1.60--1.60-5.83-2.11-2.11-
Price to Book Ratio-67.01--67.01-6.90--15.03--15.03-
Price-to-Total Gains Ratio-1.60--1.60-5.83-2.11-2.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0062
Number of shares161290
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.690.00
Usd Total Gains Per Share-0.690.00
Gains per Quarter (161290 shares)-111,299.67-664.95
Gains per Year (161290 shares)-445,198.70-2,659.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-445199-4452090-2660-2670
20-890397-8904080-5320-5330
30-1335596-13356070-7979-7990
40-1780795-17808060-10639-10650
50-2225993-22260050-13299-13310
60-2671192-26712040-15959-15970
70-3116391-31164030-18618-18630
80-3561590-35616020-21278-21290
90-4006788-40068010-23938-23950
100-4451987-44520000-26598-26610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Better Therapeutics Inc

About Better Therapeutics Inc

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-21 22:52:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Better Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Better Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Better Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-28,008.0%+28,008.0%
5Y-28,008.0%10Y-28,008.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y-28,008.0%-436.8%-27,571.2%
10Y-28,008.0%-597.3%-27,410.7%
1.1.2. Return on Assets

Shows how efficient Better Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • -173.3% Return on Assets means that Better Therapeutics Inc generated $-1.73 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Better Therapeutics Inc:

  • The MRQ is -173.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -173.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-173.3%TTM-173.3%0.0%
TTM-173.3%YOY-79.2%-94.1%
TTM-173.3%5Y-117.8%-55.5%
5Y-117.8%10Y-117.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-173.3%-13.3%-160.0%
TTM-173.3%-12.8%-160.5%
YOY-79.2%-11.6%-67.6%
5Y-117.8%-13.8%-104.0%
10Y-117.8%-15.6%-102.2%
1.1.3. Return on Equity

Shows how efficient Better Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Better Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Better Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-109.8%+109.8%
TTM-5Y-27.5%+27.5%
5Y-27.5%10Y-27.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-109.8%-14.9%-94.9%
5Y-27.5%-19.3%-8.2%
10Y-27.5%-20.1%-7.4%

1.2. Operating Efficiency of Better Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Better Therapeutics Inc is operating .

  • Measures how much profit Better Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Better Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-27,777.4%+27,777.4%
5Y-27,777.4%10Y-27,777.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y-27,777.4%-486.2%-27,291.2%
10Y-27,777.4%-628.4%-27,149.0%
1.2.2. Operating Ratio

Measures how efficient Better Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Better Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y278.274-278.274
5Y278.27410Y278.2740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y278.2745.679+272.595
10Y278.2747.823+270.451

1.3. Liquidity of Better Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Better Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.37 means the company has $1.37 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Better Therapeutics Inc:

  • The MRQ is 1.367. The company is just able to pay all its short-term debts.
  • The TTM is 1.367. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.367TTM1.3670.000
TTM1.367YOY9.561-8.194
TTM1.3675Y3.428-2.061
5Y3.42810Y3.4280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3673.863-2.496
TTM1.3674.169-2.802
YOY9.5615.337+4.224
5Y3.4286.122-2.694
10Y3.4286.434-3.006
1.3.2. Quick Ratio

Measures if Better Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.17 means the company can pay off $1.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Better Therapeutics Inc:

  • The MRQ is 1.166. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.166. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.166TTM1.1660.000
TTM1.166YOY8.629-7.463
TTM1.1665Y2.977-1.810
5Y2.97710Y2.9770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1663.504-2.338
TTM1.1663.991-2.825
YOY8.6295.371+3.258
5Y2.9776.088-3.111
10Y2.9776.395-3.418

1.4. Solvency of Better Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Better Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Better Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.04 means that Better Therapeutics Inc assets are financed with 103.9% credit (debt) and the remaining percentage (100% - 103.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Better Therapeutics Inc:

  • The MRQ is 1.039. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.039. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.039TTM1.0390.000
TTM1.039YOY0.279+0.760
TTM1.0395Y1.125-0.086
5Y1.12510Y1.1250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0390.339+0.700
TTM1.0390.337+0.702
YOY0.2790.271+0.008
5Y1.1250.368+0.757
10Y1.1250.388+0.737
1.4.2. Debt to Equity Ratio

Measures if Better Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Better Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.388-0.388
TTM-5Y0.097-0.097
5Y0.09710Y0.0970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY0.3880.335+0.053
5Y0.0970.427-0.330
10Y0.0970.461-0.364

2. Market Valuation of Better Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Better Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Better Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -1.52 means the investor is paying $-1.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Better Therapeutics Inc:

  • The EOD is -0.009. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.515. Based on the earnings, the company is expensive. -2
  • The TTM is -1.515. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.009MRQ-1.515+1.507
MRQ-1.515TTM-1.5150.000
TTM-1.515YOY-6.285+4.770
TTM-1.5155Y-1.950+0.435
5Y-1.95010Y-1.9500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.009-2.300+2.291
MRQ-1.515-2.656+1.141
TTM-1.515-2.718+1.203
YOY-6.285-4.145-2.140
5Y-1.950-6.258+4.308
10Y-1.950-6.315+4.365
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Better Therapeutics Inc:

  • The EOD is -0.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.001. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.011MRQ-2.001+1.989
MRQ-2.001TTM-2.0010.000
TTM-2.001YOY-7.949+5.949
TTM-2.0015Y-2.488+0.487
5Y-2.48810Y-2.4880.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.011-2.974+2.963
MRQ-2.001-3.306+1.305
TTM-2.001-3.508+1.507
YOY-7.949-5.613-2.336
5Y-2.488-8.378+5.890
10Y-2.488-8.873+6.385
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Better Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -67.01 means the investor is paying $-67.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Better Therapeutics Inc:

  • The EOD is -0.376. Based on the equity, the company is expensive. -2
  • The MRQ is -67.007. Based on the equity, the company is expensive. -2
  • The TTM is -67.007. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.376MRQ-67.007+66.632
MRQ-67.007TTM-67.0070.000
TTM-67.007YOY6.904-73.911
TTM-67.0075Y-15.026-51.982
5Y-15.02610Y-15.0260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.3761.914-2.290
MRQ-67.0072.116-69.123
TTM-67.0072.097-69.104
YOY6.9042.881+4.023
5Y-15.0263.550-18.576
10Y-15.0263.936-18.962
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Better Therapeutics Inc.

3.1. Institutions holding Better Therapeutics Inc

Institutions are holding 2.947% of the shares of Better Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Mmcap International Inc. Spc0.65350.0119356270-1226809-77.4951
2023-12-31Vanguard Group Inc0.36350198154-301743-60.361
2023-12-31Geode Capital Management, LLC0.309701688216194357.9567
2023-12-31Millennium Management LLC0.2362012874991876249.1688
2023-12-31BlackRock Inc0.1626088635-390-0.4381
2023-12-31Capital Investment Advisory Services, LLC0.13020.0013710003000073.1707
2023-12-31State Street Corporation0.107505860000
2023-12-31Susquehanna International Group, LLP0.0698038057380570
2023-12-31CI Private Wealth LLC0.0535029180291800
2023-09-30Citadel Advisors Llc0.048026166261660
2023-12-31HRT FINANCIAL LLC0.0464025312253120
2023-12-31Tower Research Capital LLC0.04120.000122443-425-1.8585
2023-12-31Northern Trust Corp0.030601670300
2023-12-31Ameriprise Financial Inc0.027501500000
2023-12-31XTX Topco Ltd0.02650.000614472144720
2023-12-31Group One Trading, LP0.019010351-8347-44.6411
2023-12-31JANE STREET GROUP, LLC0.019010336103360
2023-12-31Royal Bank of Canada0.00110584390201.0309
2023-12-31Bank of America Corp0.000402162160
2023-12-31Aspire Private Capital, LLC0.0004020000
Total 2.34660.01391279249-1209766-94.6%

3.2. Funds holding Better Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.3635019815400
2024-01-31Fidelity Extended Market Index0.153408362300
2024-01-31Fidelity Nasdaq Composite Index0.12640.00016892900
2023-09-30BlackRock Extended Mkt Composite0.10490.00025717900
2023-12-31BlackRock Extended Equity Market K0.09150.000149884-100-0.2001
2024-02-29iShares Micro-Cap ETF0.05490.00052995200
2024-01-31Fidelity Series Total Market Index0.024201317200
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.018401000400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.014708035150.187
2023-12-31NT Ext Equity Mkt Idx Fd - L0.01230669900
2023-12-31Northern Trust Extended Eq Market Idx0.01230669900
2023-12-31Extended Equity Market Fund M0.01130.000161682945.0051
2023-12-31SSgA U.S. Extended Market Index Class I0.00770420000
2024-02-29State St US Extended Mkt Indx NL Cl C0.00770420000
2024-01-31Spartan Total Market Index Pool E0.00570309700
2023-12-31SSgA U.S. Total Market Index Strategy0.002201211-28-2.2599
2024-01-311290 VT Micro Cap K0.0020.0002111300
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0006032310.3106
Total 1.01370.0012552642+182+0.0%

3.3. Insider Transactions

Insiders are holding 53.336% of the shares of Better Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-07-27Andrew J ArmaninoBUY2740100.73
2023-07-27David P PerryBUY12330450.73
2023-07-27Frank KarbeBUY1370050.73
2023-07-27Mark A BermanBUY548020.73
2023-05-16Elder GrangerBUY6000.87
2023-04-10Frank KarbeBUY2424240.82
2023-04-10Geoffrey M ParkerBUY3030300.82

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Better Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.690-0.6900%0.798-187%-0.004-99%-0.004-99%
Book Value Per Share---0.016-0.0160%0.674-102%0.131-113%0.131-113%
Current Ratio--1.3671.3670%9.561-86%3.428-60%3.428-60%
Debt To Asset Ratio--1.0391.0390%0.279+272%1.125-8%1.125-8%
Debt To Equity Ratio----0%0.388-100%0.097-100%0.097-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.729-0.7290%-0.740+1%-0.452-38%-0.452-38%
Free Cash Flow Per Share---0.552-0.5520%-0.585+6%-0.362-34%-0.362-34%
Free Cash Flow To Equity Per Share---0.455-0.4550%0.742-161%0.068-774%0.068-774%
Gross Profit Margin--1.1761.1760%1.058+11%1.084+8%1.084+8%
Intrinsic Value_10Y_max---9.456--------
Intrinsic Value_10Y_min---7.935--------
Intrinsic Value_1Y_max---0.542--------
Intrinsic Value_1Y_min---0.526--------
Intrinsic Value_3Y_max---1.937--------
Intrinsic Value_3Y_min---1.824--------
Intrinsic Value_5Y_max---3.705--------
Intrinsic Value_5Y_min---3.376--------
Market Cap337996.720-17723%60239738.00060239738.0000%253497540.000-76%78434319.500-23%78434319.500-23%
Net Profit Margin----0%-0%-280.0800%-280.0800%
Operating Margin----0%-0%-277.7740%-277.7740%
Operating Ratio----0%-0%278.274-100%278.274-100%
Pb Ratio-0.376+99%-67.007-67.0070%6.904-1071%-15.026-78%-15.026-78%
Pe Ratio-0.009+99%-1.515-1.5150%-6.285+315%-1.950+29%-1.950+29%
Price Per Share0.006-17723%1.1051.1050%4.650-76%1.439-23%1.439-23%
Price To Free Cash Flow Ratio-0.011+99%-2.001-2.0010%-7.949+297%-2.488+24%-2.488+24%
Price To Total Gains Ratio-0.009+99%-1.601-1.6010%5.830-127%2.115-176%2.115-176%
Quick Ratio--1.1661.1660%8.629-86%2.977-61%2.977-61%
Return On Assets---1.733-1.7330%-0.792-54%-1.178-32%-1.178-32%
Return On Equity----0%-1.0980%-0.2750%-0.2750%
Total Gains Per Share---0.690-0.6900%0.798-187%-0.004-99%-0.004-99%
Usd Book Value---899000.000-899000.0000%36720000.000-102%7114500.000-113%7114500.000-113%
Usd Book Value Change Per Share---0.690-0.6900%0.798-187%-0.004-99%-0.004-99%
Usd Book Value Per Share---0.016-0.0160%0.674-102%0.131-113%0.131-113%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.729-0.7290%-0.740+1%-0.452-38%-0.452-38%
Usd Free Cash Flow---30110000.000-30110000.0000%-31889000.000+6%-19757750.000-34%-19757750.000-34%
Usd Free Cash Flow Per Share---0.552-0.5520%-0.585+6%-0.362-34%-0.362-34%
Usd Free Cash Flow To Equity Per Share---0.455-0.4550%0.742-161%0.068-774%0.068-774%
Usd Market Cap337996.720-17723%60239738.00060239738.0000%253497540.000-76%78434319.500-23%78434319.500-23%
Usd Price Per Share0.006-17723%1.1051.1050%4.650-76%1.439-23%1.439-23%
Usd Profit---39760000.000-39760000.0000%-40335000.000+1%-23069250.000-42%-23069250.000-42%
Usd Revenue----0%-0%6500.000-100%6500.000-100%
Usd Total Gains Per Share---0.690-0.6900%0.798-187%-0.004-99%-0.004-99%
 EOD+2 -6MRQTTM+0 -0YOY+10 -195Y+6 -2510Y+6 -25

4.2. Fundamental Score

Let's check the fundamental score of Better Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.009
Price to Book Ratio (EOD)Between0-1-0.376
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.166
Current Ratio (MRQ)Greater than11.367
Debt to Asset Ratio (MRQ)Less than11.039
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.733
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Better Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.126
Ma 20Greater thanMa 500.011
Ma 50Greater thanMa 1000.094
Ma 100Greater thanMa 2000.148
OpenGreater thanClose0.005
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets22,943
Total Liabilities23,842
Total Stockholder Equity-899
 As reported
Total Liabilities 23,842
Total Stockholder Equity+ -899
Total Assets = 22,943

Assets

Total Assets22,943
Total Current Assets18,446
Long-term Assets4,497
Total Current Assets
Cash And Cash Equivalents 15,740
Other Current Assets 210
Total Current Assets  (as reported)18,446
Total Current Assets  (calculated)15,950
+/- 2,496
Long-term Assets
Property Plant Equipment 121
Intangible Assets 3,888
Other Assets 488
Long-term Assets  (as reported)4,497
Long-term Assets  (calculated)4,497
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,494
Long-term Liabilities10,348
Total Stockholder Equity-899
Total Current Liabilities
Short-term Debt 4,532
Short Long Term Debt 4,532
Accounts payable 3,035
Other Current Liabilities 5,927
Total Current Liabilities  (as reported)13,494
Total Current Liabilities  (calculated)18,026
+/- 4,532
Long-term Liabilities
Long term Debt 10,348
Long-term Liabilities  (as reported)10,348
Long-term Liabilities  (calculated)10,348
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -111,503
Other Stockholders Equity 110,602
Total Stockholder Equity (as reported)-899
Total Stockholder Equity (calculated)-899
+/-0
Other
Capital Stock2
Cash and Short Term Investments 15,740
Common Stock Shares Outstanding 23,558
Liabilities and Stockholders Equity 22,943
Net Debt -860
Net Invested Capital 13,981
Net Tangible Assets -4,787
Net Working Capital 4,952
Property Plant and Equipment Gross 178
Short Long Term Debt Total 14,880



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-31
> Total Assets 
4,881
6,387
50,958
22,943
22,94350,9586,3874,881
   > Total Current Assets 
987
463
45,251
18,446
18,44645,251463987
       Cash And Cash Equivalents 
757
123
40,566
15,740
15,74040,566123757
       Net Receivables 
0
216
276
0
02762160
       Other Current Assets 
0
216
276
210
2102762160
   > Long-term Assets 
3,894
5,924
5,707
4,497
4,4975,7075,9243,894
       Property Plant Equipment 
183
89
82
121
1218289183
       Intangible Assets 
3,267
5,555
5,077
3,888
3,8885,0775,5553,267
       Other Assets 
444
280
548
488
488548280444
> Total Liabilities 
5,486
13,145
14,238
23,842
23,84214,23813,1455,486
   > Total Current Liabilities 
486
613
4,733
13,494
13,4944,733613486
       Short-term Debt 
0
0
0
4,532
4,532000
       Short Long Term Debt 
0
0
0
4,532
4,532000
       Accounts payable 
335
514
1,523
3,035
3,0351,523514335
       Other Current Liabilities 
151
99
3,210
5,927
5,9273,21099151
   > Long-term Liabilities 
5,000
12,532
9,505
10,348
10,3489,50512,5325,000
       Long term Debt 
5,000
640
9,505
10,348
10,3489,5056405,000
       Other Liabilities 
0
11,892
0
0
0011,8920
       Long-term Liabilities Other 
0
11,740
0
0
0011,7400
       Deferred Long Term Liability 
0
62
0
0
00620
> Total Stockholder Equity
-605
-6,758
36,720
-899
-89936,720-6,758-605
   Common Stock
212
1
2
2
221212
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 0000
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
0
445
108,461
110,602
110,602108,4614450



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-29,613
Operating Income-29,613-29,613
 
Operating Expense (+$)
Research Development10,511
Selling General Administrative19,102
Selling And Marketing Expenses-
Operating Expense29,61329,613
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,951
Other Finance Cost-0
Net Interest Income-1,951
 
Pretax Income (+$)
Operating Income-29,613
Net Interest Income-1,951
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-31,564-29,613
EBIT - interestExpense = -1,951
-31,573
-29,622
Interest Expense1,951
Earnings Before Interest and Taxes (EBIT)--29,613
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-31,564
Tax Provision-9
Net Income From Continuing Ops-31,573-31,573
Net Income-31,573
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,951
 

Technical Analysis of Better Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Better Therapeutics Inc. The general trend of Better Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Better Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Better Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.012 < 0.012 < 0.0135.

The bearish price targets are: 0.005.

Tweet this
Better Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Better Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Better Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Better Therapeutics Inc. The current macd is -0.02313339.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Better Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Better Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Better Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Better Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBetter Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Better Therapeutics Inc. The current adx is 40.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Better Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Better Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Better Therapeutics Inc. The current sar is 0.01691259.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Better Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Better Therapeutics Inc. The current rsi is 27.13. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Better Therapeutics Inc Daily Relative Strength Index (RSI) ChartBetter Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Better Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Better Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Better Therapeutics Inc Daily Stochastic Oscillator ChartBetter Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Better Therapeutics Inc. The current cci is -124.38478747.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Better Therapeutics Inc Daily Commodity Channel Index (CCI) ChartBetter Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Better Therapeutics Inc. The current cmo is -50.88347753.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Better Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartBetter Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Better Therapeutics Inc. The current willr is -86.51685393.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Better Therapeutics Inc Daily Williams %R ChartBetter Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Better Therapeutics Inc.

Better Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Better Therapeutics Inc. The current atr is 0.00984594.

Better Therapeutics Inc Daily Average True Range (ATR) ChartBetter Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Better Therapeutics Inc. The current obv is 332,785,874.

Better Therapeutics Inc Daily On-Balance Volume (OBV) ChartBetter Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Better Therapeutics Inc. The current mfi is 44.54.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Better Therapeutics Inc Daily Money Flow Index (MFI) ChartBetter Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Better Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Better Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Better Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.126
Ma 20Greater thanMa 500.011
Ma 50Greater thanMa 1000.094
Ma 100Greater thanMa 2000.148
OpenGreater thanClose0.005
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Better Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Better Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Better Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Better Therapeutics Inc

I send you an email if I find something interesting about Better Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Better Therapeutics Inc.

Receive notifications about Better Therapeutics Inc in your mailbox!